» Articles » PMID: 32595443

TDP-43 Is Efficiently Transferred Between Neuron-Like Cells in a Manner Enhanced by Preservation of Its N-Terminus but Independent of Extracellular Vesicles

Overview
Journal Front Neurosci
Date 2020 Jun 30
PMID 32595443
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The misfolding of transactive response DNA-binding protein (TDP-43) is a major contributor to the pathogenesis of TDP-43 proteinopathies, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with TDP-43 inclusions, but also plays a role in other neurodegenerative diseases including Alzheimer disease. It is thought that different truncations at the N- and C-termini of TDP-43 contribute to its misfolding and aggregation in the brain, and that these aberrant TDP-43 fragments contribute to disease. Despite this, little is known about whether different truncation events influence the protein's transmissibility between cells and how this cell-to-cell transfer occurs. In this study, we use a well-established cellular model to study the efficiency by which full-length and truncated TDP-43 fragments are transferred between neuron-like cells. We demonstrate that preservation of the N-terminus of TDP-43 enhances its transmissibility between cells and that this protein transmission occurs in a manner exclusive of extracellular vesicles, instead requiring cellular proximity for efficient propagation. These data indicate that the N-terminus of TDP-43 might be a useful target in the generation of therapeutics to limit the spread of TDP-43 pathology.

Citing Articles

Prion-like Spreading of Disease in TDP-43 Proteinopathies.

Pongracova E, Buratti E, Romano M Brain Sci. 2024; 14(11).

PMID: 39595895 PMC: 11591745. DOI: 10.3390/brainsci14111132.


Conserved region of human TDP-43 is structurally similar to membrane binding protein FARP1 and protein chaperons BAG6 and CYP33.

Sjekloca L, Buratti E MicroPubl Biol. 2024; 2024.

PMID: 39583578 PMC: 11582883. DOI: 10.17912/micropub.biology.001388.


Amyotrophic lateral sclerosis.

Feldman E, Goutman S, Petri S, Mazzini L, Savelieff M, Shaw P Lancet. 2022; 400(10360):1363-1380.

PMID: 36116464 PMC: 10089700. DOI: 10.1016/S0140-6736(22)01272-7.


Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.

Goutman S, Hardiman O, Al-Chalabi A, Chio A, Savelieff M, Kiernan M Lancet Neurol. 2022; 21(5):465-479.

PMID: 35334234 PMC: 9513754. DOI: 10.1016/S1474-4422(21)00414-2.


Mechanisms of TDP-43 Proteinopathy Onset and Propagation.

Chen H, Mitchell J Int J Mol Sci. 2021; 22(11).

PMID: 34199367 PMC: 8199531. DOI: 10.3390/ijms22116004.


References
1.
James B, Wilson R, Boyle P, Trojanowski J, Bennett D, Schneider J . TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016; 139(11):2983-2993. PMC: 5091047. DOI: 10.1093/brain/aww224. View

2.
Brettschneider J, Del Tredici K, Toledo J, Robinson J, Irwin D, Grossman M . Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol. 2013; 74(1):20-38. PMC: 3785076. DOI: 10.1002/ana.23937. View

3.
Luk K, Kehm V, Carroll J, Zhang B, OBrien P, Trojanowski J . Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012; 338(6109):949-53. PMC: 3552321. DOI: 10.1126/science.1227157. View

4.
Shimonaka S, Nonaka T, Suzuki G, Hisanaga S, Hasegawa M . Templated Aggregation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Seeding with TDP-43 Peptide Fibrils. J Biol Chem. 2016; 291(17):8896-907. PMC: 4861459. DOI: 10.1074/jbc.M115.713552. View

5.
Gustafsson G, Loov C, Persson E, Lazaro D, Takeda S, Bergstrom J . Secretion and Uptake of α-Synuclein Via Extracellular Vesicles in Cultured Cells. Cell Mol Neurobiol. 2018; 38(8):1539-1550. PMC: 6223723. DOI: 10.1007/s10571-018-0622-5. View